Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Top Cited Papers
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 55 (3) , 329-347
- https://doi.org/10.1016/s0169-409x(02)00228-4
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivoGene Therapy, 2002
- Long-term (≥8 years) outcome after palmaz-schatz stent implantationThe American Journal of Cardiology, 2001
- Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoidJournal of Microencapsulation, 2001
- Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)The American Journal of Cardiology, 2000
- Intracellular Regulation of Macromolecules Using pH-Sensitive Liposomes and Nuclear Localization Signal: Qualitative and Quantitative Evaluation of Intracellular TraffickingBiochemical and Biophysical Research Communications, 1998
- Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: Effects on restenosis and implications for catheter-based drug deliveryJournal of the American College of Cardiology, 1995
- Restenosis: The cost to societyAmerican Heart Journal, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Molecular biology: Insight into the causes and prevention of restenosis after arterial interventionThe American Journal of Cardiology, 1993
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992